Biogen, Inc. (previously known as Biogen Idec) is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.HistoryBiogen was founded in 1978 in Geneva by several prominent biologists, including Kenneth Murray of the University of Edinburgh, Phillip Allen Sharp of the Massachusetts Institute of Technology, Walter Gilbert of Harvard (who served as CEO during the start-up phase), Heinz Schaller, University of Heidelberg and Charles Weissmann, University of Zurich (who contributed the first product interferon alpha). Gilbert and Sharp were subsequently honored with Nobel Prizes: Gilbert was recognized in 1980 with the Nobel Prize in Chemistry for his work in understanding DNA sequencing, while Sharp received the Nobel Prize in Physiology or Medicine in 1993 for his discovery of split genes.

Type
Public
HQ
Cambridge, US
Founded
1978
Employees
7,350 (est)
Biogen was founded in 1978 and is headquartered in Cambridge, US

Biogen Locations

Cambridge, US

Biogen Metrics

Biogen Summary

Market capitalization

$62 B

Closing share price

$291
Biogen's latest market capitalization is $62 B.

Biogen Market Value History

Biogen Online Presence

Biogen News

Biogen Company Life

You may also be interested in